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Deficiency for Public Health
Adrian Dubock
Abstract
Vitamin A deficiency (VAD) has been recognised as a significant public health 
problem continuously for more than 30 years, despite current interventions. The 
problem is particularly severe in populations where rice is the staple food and 
diversity of diet is limited, as white rice contains no micronutrients. Golden Rice is a 
public-sector product designed as an additional intervention for VAD. There will be 
no charge for the nutritional trait, which has been donated by its inventors for use 
in public-sector rice varieties to assist the resource poor, and no limitations on what 
small farmers can do with the crop—saving and replanting seed, selling seed and 
selling grain are all possible. Because Golden Rice had to be created by introducing 
two new genes—one from maize and the other from a very commonly ingested soil 
bacterium—it has taken a long time to get from the laboratory to the field. Now 
it has been formally registered as safe as food, feed, or in processed form by four 
industrialised counties, and applications are pending in developing countries. The 
data are summarised here, and criticisms addressed, for a public health professional 
audience: is it needed, will it work, is it safe and is it economic? Adoption of Golden 
Rice, the next step after in-country registration, requires strategic and tactical 
cooperation across professions, non-governmental organisations (NGOs) and 
government departments often not used to working together. Public health profes-
sionals need to play a prominent role.
Keywords: Golden Rice, VAD, biofortification, β-carotene, micronutrients, estimated 
average requirement (EAR), recommended daily allowance (RDA), novel proteins, 
allergenicity, substantial equivalence, hidden hunger
1. Introduction
Research was initiated in the early 1990s which led in 2000 to the publication 
of the technology behind what came to be known as Golden Rice [1, 2]. From the 
outset, the intention was to create a source of vitamin A in the endosperm of rice, 
as an additional intervention for vitamin A deficiency. Philanthropy and the public 
sector funded the research [1]. In 2001, the inventors, Professor Ingo Potrykus 
and Dr. (now Professor) Peter Beyer, assigned their patents to Syngenta for com-
mercial exploitation as part of a transaction which obliged the company to assist 
the inventors’ humanitarian and altruistic objectives [1, 3, 4]. At the same time, the 
nutritional technology was donated by its inventors for use in developing countries 
[3, 4]. The inventors licenced a network of Asian government-owned rice research 
institutes to deliver their objectives. Product development was initiated through the 
International Rice Research Institute (IRRI) and the network. The whole network, 
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including IRRI, worked to a common set of goals defined in licences each institution 
signed with the inventors. The terms included that there would be no charge for 
the nutritional technology and it would only be introduced to publicly owned rice 
varieties. Improvements were made to the technology by Syngenta scientists [5]. In 
2005 and 2006, pursuant to Syngenta’s legal obligations entered into with the inven-
tors in 2001, Syngenta provided selected transformation events of the improvements 
to the Golden Rice Humanitarian Board. The Humanitarian Board, via Syngenta 
and IRRI, made these new versions available to the Golden Rice licensee network 
[4, 6]. In 2004 Syngenta ceased its commercial interest in Golden Rice [7]. From 
2004 development was again only funded by philanthropy and the public sector; the 
national budgets of Bangladesh, China, India, Indonesia, Philippines and Vietnam; 
as well as the US National Institutes of Health together with the Rockefeller and Bill 
& Melinda Gates Foundations and USAID. Golden Rice is a not-for-profit project: 
no individual, nor organisation involved with its development, has any financial 
interest in the outcome.
To date the Golden Rice project has principally engaged plant scientists. Activist 
opposition to Golden Rice has been led principally by non-scientists, who have 
been very successful in developing a narrative about Golden Rice and gmo crops 
which serves the activist’s purpose1 but is fundamentally inaccurate [8]. Further 
background to the development of Golden Rice, including the political dimensions, 
is detailed elsewhere [6, 9, 10].
A few years ago, at Tufts University, USA, I gave a presentation about Golden 
Rice. The symposium was organised by the Friedman School of Nutrition Science 
and Policy whose strategic aims today include ‘Reduce nutrition-related health 
inequities’ and ‘Promote food systems that increase agricultural sustainability 
while improving human health’ [11]. I was dismayed to learn that the anti-gmo and 
anti-Golden Rice activists’ narrative was widely accepted by the participants—all of 
whom were studying or working in nutrition and well aware of nutritional inequi-
ties in public health.
Without adoption, that is, regular growth and consumption of Golden Rice by 
populations in countries where rice is the staple and VAD is problematic, Golden 
Rice cannot deliver any public health and welfare benefits. Adoption requires 
cooperative working by different specialists, including medical, nutritional and 
public health specialists [12]. This chapter is designed to answer anticipated ques-
tions from such specialists, to facilitate adoption of Golden Rice as an additional 
intervention for vitamin A deficiency.
2. Rice, diet and deficiency
Rice is the most important staple crop [6]: more than half of the global popula-
tion eats it every day. In some countries, 70–80% of an individual’s calorie intake is 
from consumption of rice [13, 14].
For storage without becoming rancid, the husk and the aleurone layer of rice 
have to be removed. What remains after polishing-white rice, the endosperm-
contains small amounts of fat and is an excellent source of carbohydrate for energy 
but contains no micronutrients. Yet humans require both macronutrients (carbohy-
drates, proteins, fats) and micronutrients (minerals and vitamins) for a healthy life. 
Like all plants, rice obtains its minerals from the soil. Vitamins are synthesised by 
plants and/or animals, including humans.
1 For example: https://www.heartland.org/_template-assets/documents/12-3-18%20Analysis%20of%20
Greenpeace%20Business%20Model.pdf
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Human health is best served by a ‘balanced diet’ that is varied, containing both 
macronutrients and micronutrients, including animal products and, as sources 
of provitamin A, coloured fruits and vegetables. Micronutrient sources are insuf-
ficiently represented in the diets of many people in countries where rice is the 
staple. The reasons often include poverty: such dietary components are expensive 
compared to the cost of rice [15]. In countries where rice is the staple, the aver-
age consumption is 75.20 kg/capita/year. Of those countries where micronutrient 
deficiencies are common, consumption increases to 150 kg/capita/year [16]. In such 
populations micronutrient deficiencies, like poverty itself, often occur as part of an 
intergenerational cycle [17].
For the past 15 years, 800 million people—more than 10% of the global popula-
tion—are hungry every day. These chronically hungry individuals lack sufficient 
calories in their daily diet [18–20]; indeed over the past 3 years, the trend is upward 
[20]. Even more alarming is that 2 billion people—almost 25% of global popula-
tion—are micronutrient deficient; they suffer from ‘hidden hunger’, with important 
associated morbidity and mortality [17] and related economic impact [6, 17]. 
Figure 1 shows that over the 20-year period 1990–2010, the rate of reduction of 
chronic hunger (that is, macronutrient—carbohydrate, proteins and fats—dietary 
insufficiency) has been faster than the rate of reduction for hidden hunger (that 
is, dietary insufficiency of minerals and vitamins) [21] Dr. Matin Qaim, member 
of the Golden Rice Humanitarian Board and one of the authors of the paper from 
which Figure 1 is extracted, has commented: ‘In the future the hidden hunger [e.g. 
micronutrient deficiency] burden will be larger, [than chronic hunger – principally 
carbohydrate deficiency] unless targeted efforts to reduce micronutrient malnutri-
tion are implemented at larger scale’ (pers comm: Dr. M Qaim).
Interventions for micronutrient deficiencies include supplementation  
(with pills, syrups or capsules containing micronutrients [22]) and fortification 
(adding micronutrients to processed food). Both interventions require some level 
of  manufacturing and/or distribution infrastructure.
With the creation of Golden Rice in 1999 [2]—the first purposefully created 
biofortified crop—a new term was required: ‘biofortification’. The word was first 
used in 2002 [23] and first defined in 2004 [24]: “biofortification” is a word coined 
Figure 1. 
Disability-adjusted life years (DALYs) lost due to chronic hunger and hidden hunger between 1990 and 2010. 
Please refer to text for further explanation (Figure 1 here is part of Figure 2 from Ref. [21]).
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to refer to increasing the bioavailable micronutrient content of food crops through 
genetic selection via plant breeding.’ In 2003 ‘Harvest Plus’ a not-for-profit public-
sector programme started to biofortify staple crops by conventional plant breeding, 
to benefit the poor, and progress with biofortification through conventional plant 
breeding was rewarded by the World Food Prize in 2016 [25].
The intention of biofortification is to deliver public health benefits to popula-
tions which are micronutrient deficient, through consumption of the staple 
crop including the extra nutrition within the edible part of the crop. In this 
way minimal cultural change is required to food—production, processing or 
consumption—systems. For the most marginal members of the population, 
this biofortification approach overcomes the inherent access, cost and non-
sustainability difficulties of supplementation and fortification. In 2017 the World 
Bank recommended that biofortified staple crops should be the norm rather than 
the exception: ‘conventionally’ bred biofortified crops and also genetically engi-
neered crops—gmo crops—were both recommended with Golden Rice specifically 
mentioned [26].
For Golden Rice to deliver benefits, it has to be grown and consumed within 
target countries where VAD remains problematic despite significant progress with 
other interventions, notably vitamin A capsules, which have undoubtedly saved 
millions of lives and will save more, since they were introduced (accompanied by 
controversy) in the 1990s [15, 22]. And success or failure with Golden Rice will 
directly affect future adoption also of high zinc, high iron and high folate rice and 
their impact on public health for hundreds of millions of people. All these traits, 
introduced to the endosperm of rice, necessitated using gmo techniques [16, 27], 
and all cost no more than white rice to the grower or consumer. Eventually, as the 
end point of product development, it is planned to include all these nutritional 
traits together in multi-micronutrient-Golden Rice.
Adoption of Golden Rice requires public health professionals as well as agricultural 
and other professionals, to work together in each country [12]. Any scepticism created 
by the past 18 years of negative activist influence will prevent success, if not positively 
addressed by all involved. For billions of people, the stakes could not be higher.
3. The questions and answers
3.1 Is Golden Rice needed?
For more than a quarter of a century, vitamin A deficiency (VAD) has been 
recognised by the United Nations as a significant public health problem. Key 
milestones included the:
1990 United Nations (UN) World Summit for Children, where 50 heads of 
government and senior government officials committed their governments to the 
virtual elimination of VAD by the year 2000 [28].
1992 UN International Conference on Nutrition, which concluded that
• VAD control is the most cost-effective child health/survival strategy govern-
ments can pursue.
• All sectors of society should support the virtual elimination of VAD.
• Strategies should include promoting breast-feeding, dietary diversification, 
vitamin A supplementation and food fortification.
• Locally available food-based strategies are the first priority. Vitamin A capsule 
supplementation is only an interim measure [29].
5Golden Rice: To Combat Vitamin A Deficiency for Public Health
DOI: http://dx.doi.org/10.5772/intechopen.84445
2004 United Nations International Children’s Emergency Fund (UNICEF) 
and the Micronutrient Initiative Report ‘Vitamin and Mineral Deficiency’, 
which concluded that ‘controlling vitamin and mineral deficiency is an affordable 
opportunity to improve the lives of two billion people and strengthen the pulse of 
economic development’ and that ‘probably no other technology available today 
offers as large an opportunity to improve lives and accelerate development at such 
low cost’ [30].
Nevertheless, vitamin A deficiency (VAD) remains a major public health 
problem, in more than half of all countries, especially in Africa and south-east Asia 
(Figure 2), hitting hardest young children and pregnant women [31] especially in 
countries where rice is the staple food. Food sources that are most valuable in terms 
of micronutrients—for vitamin A, animal products including milk, eggs, butter, 
liver and fish—are usually more expensive and ‘beyond the reach of poor families’ 
[15]. Food security staple crops such as rice are cheaper and therefore make up most 
of the diet.
The problem of VAD is exacerbated by the limited bioavailability of vitamin A 
from fruit and vegetables [33]. It has been estimated that young children between ages 
1 and 3 years would need to eat eight servings of dark green leafy vegetables per day 
in order to meet the recommended dietary allowance (‘RDA’) for vitamin A. These 
facts have resulted in the conclusion of ‘the virtual impossibility for most poor, young 
children to meet their vitamin A requirements through vegetable and fruit intake 
alone’ [15].
VAD is the principal cause of irreversible blindness in children [34]. Another 
morbidity of VAD is related to impairment of the immune system [15]: most 
children and mothers who die as a result of VAD do not become blind first but die 
of common childhood diseases. VAD is a nutritionally acquired immune deficiency 
syndrome [15]. Increased susceptibility to disease as a result of VAD results in the 
majority of the millions of preventable deaths annually, mainly of children less 
than 5 years old (<5 years) [22]. Meta-analyses have shown that 23–34% of global 
mortality of children <5 years can be prevented by a universally available source of 
vitamin A [22, 35, 36] and up to 50% for measles sufferers [31]. As the UN regularly 
 
 
 
 
 Clinical
Severe: subclinical
Moderate: subclinical 
Mild: sporadic or 
high risk
No data: problem likely
Figure 2. 
Public health importance for vitamin A deficiency, by country. Source [32] (the original WHO map has been 
redrawn and is provided here by courtesy of Banson, a publisher).
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measures and publishes global all-cause child mortality, the importance of VAD 
mortality can be stated compared with other public health mortality causes, also 
reported regularly by the UN (Table 1).
In 2016, 26 years after the first UN commitment to virtually eliminate VAD by the 
year 2000 [28], and despite existing knowledge and interventions, 1.3–1.9 million, 
mostly children less than 5 years old, and many mothers, died from this preventable 
vitamin deficiency (Table 1).
3.2 Will Golden Rice work?
There is not one type of Golden Rice. The ‘genetic modification’ part of the pro-
cess used to create Golden Rice occurred only once, in about 2004 [5]. The preferred 
‘transformation event GR2E’ was selected in late 2013 [6, 9] and subsequently intro-
duced by ‘conventional plant breeding’ into more than a dozen cultivars of the Oryza 
sativa indica rice variety agronomically adapted to and preferred by the farming and 
rice-consuming populations of India and Asia. These cultivars can be grown directly 
and harvested and the polished Golden Rice sold and consumed, or the Golden Rice 
seed can be used by rice breeders as ‘parents’ to introduce the trait into any locally 
adapted and preferred rice variety, of which there are over 20,000.
The agronomy of Golden Rice—how it grows, its resistance to pests and dis-
eases, its water requirements and days to maturity and plant and grain morpholo-
gies—and yield are the same as the variety into which the nutritional trait has been 
introduced. An avoidable human error was made in an earlier selection of ‘a lead 
transformation event: GR2R’, which led to plants in open fields falling over when 
subject to wind and rain, and a small yield loss of about 2% was the result [9, 38]. 
GR2R was dropped from development in late 2013. The current lead transformation 
event, GR2E, was selected in the same year. GR2E has been, and will be, registered 
for use and has no problems associated with it [6].
In his wonderful book The Vitamin A Story: Lifting the Shadow of Death [15], the 
author Dr. Semba wrote (p. 159): ‘From a public health standpoint, for food fortifi-
cation to be effective in reducing a population’s micronutrient deficiency, the food to 
be fortified must be a dietary staple eaten daily with little or no variation. Further, 
the fortified food should reach the entire population. Of course, the fortification 
process must be economically feasible and have minimal effect on the cost of the 
food treated. The micronutrient with which the staple is treated must be chemically 
stable and undetectable by persons consuming it. Finally, to enable observation and 
measurement of results, location or processing and distribution must be finite and 
constant’. The book was published in 2012, when biofortification was known, but 
Global mortality (millions) 2010a 2014a 2016/2017
Vitamin A deficiency 1.9–2.8 1.4–2.1 1.3–1.9 (2016)b
HIV/AIDS 1.8 1.2 0.94 (2017)c
Tuberculosis (TB) 1.4 1.1 1.6 (2017)d
Malaria 0.7 0.6 0.45 (2016)e
aSource: [6]
bSource: 23–34%—see text—of 5.6 months <5 years children in 2016 [37]
cSource: http://www.unaids.org/en/resources/fact-sheet [Accessed: January 10, 2019]
dSource: https://www.who.int/news-room/fact-sheets/detail/tuberculosis [Accessed: January 10, 2019]
eSource: https://reliefweb.int/report/world/world-malaria-report-2017 [Accessed: January 10, 2019]
Table 1. 
Annual mortality from different public health diseases (VAD deaths exclude significant maternal mortality).
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not sufficiently established to have any practical history. For whatever reason, Dr. 
Semba does not mention biofortification, nor Golden Rice, in his book.
Nevertheless, for Golden Rice ‘from a public health standpoint, for food fortifi-
cation to be effective’, all the characteristics listed by Dr. Semba are satisfied, except 
when it comes to ‘undetectable by persons consuming it’. The Golden Rice colour 
is caused by the β-carotene content, a source of vitamin A for humans, which in 
Golden Rice is about 80–90% of all carotenoids [5]. It is the same β-carotene which 
colours mangos, papaya, squash and carrots, all of which consumers readily accept, 
and there is no taste associated with the β-carotene content. In Golden Rice, the 
intensity of the colour is proportional to the β-carotene content. The colour is obvi-
ous and cannot be ignored (Figure 3).
In 2009 MBA students at the Asian Institute of Management conducted qualita-
tive attitudinal surveys of small farmers and consumers in four different repre-
sentative island locations in the Philippines. Neither the colour nor the way it was 
created was considered a block to trying Golden Rice, so long as it was expected to 
assist their family’s health and was affordable. The solid colour of Golden Rice was 
recognisably distinct from the rather blotchy yellow colour of poorly stored white 
rice, which is sometimes offered cheaply by governments to assist poor people.
From several perspectives the colour of Golden Rice is positive. Consumers have 
a choice about whether to select it for cooking and whether to consume it or not. 
Such consumer choice is denied and therefore only made by governments or plant 
breeders, when the biofortified trait is ‘undetectable by persons consuming it’ [15], 
as in the case of invisible biofortificants such as iron or zinc introduced into biofor-
tified grain crops or used in fortification of processed food. The colour of Golden 
Rice makes the consumers’ choice clear, even in populations with a variety of 
languages and dialects or where individuals are illiterate: each grain of Golden Rice 
is individually labelled, by its colour. No labelling is required on any packaging, and 
preference can be beneficially affected by communication of its lack of any adverse 
associations, and anticipated health benefits, from consumption.
Eighty percent—about 380 million tonnes—of global rice production is pro-
duced on small farms for family consumption, usually unprocessed except for 
polishing [38]. It is probably not stored for long, as rice is produced, usually, in two 
or three growth cycles annually, and storage facilities are limited. Data have shown 
that degradation of the β-carotene is minimal 2 months after harvest and samples of 
Golden Rice stored in ambient temperatures for 4.5 years remain noticeably yellow, 
indicating continued presence of β-carotene [39].
In early 2001, a year after the seminal paper describing the ‘proof of concept’ 
technology [2], Greenpeace made a press release: ‘Genetically modified “Golden 
Rice” containing provitamin A will not solve the problem of malnutrition in devel-
oping countries,… Greenpeace calculations show… , that an adult would have to eat 
Figure 3. 
Polished white and Golden Rice and (a different cultivar, after 2 months of postharvest storage) after cooking.
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at least 3.7 kilos of dry weight rice, i.e. around 9 kilos of cooked rice, to satisfy their 
daily need of vitamin A from “Golden Rice” …’ [40].
It is unclear how Greenpeace came to their conclusion. At the time, it was known 
that the bioavailability of carotenoids is influenced by nine different factors [41]. But 
no one knew how efficiently the β-carotene in Golden Rice was converted to circulat-
ing vitamin A, retinol, by human adults or children. And nutritionists agreed that 
animal models would not be helpful because animals metabolise carotenoids differ-
ently than humans. Research was needed to determine how efficiently the β-carotene 
in Golden Rice is converted to circulating retinol, in children in developing countries 
where rice is the staple, the population segment which suffers most from VAD.
A February 2002 grant application to the US governments National Institutes 
of Health (NIH) for a project, which is entitled ‘Retinol Equivalents of Plant 
Carotenoids in Chinese Children’, states ‘This project is to determine the vitamin A 
value (equivalence) of dietary provitamin A carotenes from spinach, Golden Rice, 
and pure β-carotene (β-c) in oil. These experiments will be conducted in children 
(ages 6–8) with/without adequate vitamin A nutrition’.
On February 10, 2004, Tufts University Institutional Review Board (IRB) 
approved the research Protocol for ‘Retinol Equivalents of Plant carotenoids in 
Chinese Children’ and noted that ‘The Zhejiang Academy of Medical Sciences 
[China] approval is on file’.
On March 11, 2008, the Tufts IRB reviewed and on May 10, 2008, approved 
the study ‘Vitamin A Value of Plant Carotenoids (Spinach and Golden Rice in 
Children)’ based on the Protocol ‘Retinol equivalents of plant carotenoids in 
Chinese children’. Both Protocols referenced ‘NIH grant proposal 1R01 DK060021’.
On March 30, 2008, with respect to ‘Retinol Equivalents of Plant carotenoids 
in Chinese Children’ and ‘NIH Grant 1R01 DK060021-01’: The Ethical Review 
Committee of Zhejiang Academy of Medical Sciences confirmed that they had 
‘reviewed the proposed use of human subject identified on June 27, 2003’ and certi-
fied that ‘the approval notice is still valid’.
Although the Chinese children research was planned in 2003, various practical 
setbacks in the production2 of the deuterium-labelled Golden Rice [9] meant that the 
field work in China was not completed until mid-June 2008 and, due to the complex-
ity of analysis combined with limited analytical resources, publication not until 2012.
In the meantime, similar research was approved and conducted with adult 
volunteers in the USA. Data confirmed that 3.8 molecules of β-carotene derived by 
consumption of a single meal of Golden Rice converted to one molecule of circulat-
ing retinol [42]; this 3.8:1 bioconversion compared very favourably with conversion 
ratios established using other plant sources [33]. When the Chinese children research 
were published online on August 8, 2012, the authors reported a bioconversion ratio 
of 2.3:1.0, later adjusted to 2.1:1.0, and neither ratio significantly different, statisti-
cally, from the 2.0:1.0 of β-carotene in oil, another treatment in the same research. A 
third treatment, spinach, showed a 7.5:1.0 conversion. In each case the sophisticated 
research design measured the efficiency of conversion of β-carotene to circulating 
retinol following a single meal containing the β-carotene source. The publication 
noted that ‘In summary, the high bioconversion efficiency of Golden Rice β-carotene 
to vitamin A shows that this rice can be used as a source of vitamin A. Golden Rice 
may be as useful as a source of preformed vitamin A from vitamin A capsules, eggs 
or milk to overcome VAD in rice-consuming populations’ [4, 6].
These results were clearly very different from Greenpeace’s 2001 prediction. 
Instead of welcoming the excellent news of a potentially useful additional VAD 
intervention, Greenpeace, on August 29, 2012, issued a further press release in 
2 At Baylor College of Medicine, Children’s Nutrition Research Center, Houston, USA
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China from their Netherlands HQ: ‘Greenpeace alarmed at US-backed GE food trial 
on Chinese children’…‘It is incredibly disturbing to think that an American research 
body used Chinese children as guinea pigs for genetically engineered food,… 
The relevance of this study is questionable,…Nor does high conversion rate solve 
all the technical, environmental and ethical issues around Golden Rice’ [6, 10]. 
Greenpeace claimed that the Chinese authorities agreed to halt the research before 
it started3 but were unable to substantiate their claim to an independent journalist. 
The press release created hysteria in China and, 4 years after the field research had 
been completed, caused the parents of the subject children consternation.
Tufts University IRB carried out an investigation and concluded that there were 
‘no concerns related to the integrity of the study data, the accuracy of the research 
results or the safety of the research subjects. In fact, the study indicated that a single 
serving of the test product, Golden Rice, could provide greater than 50 percent of 
the recommended daily intake of vitamin A in these children, which could signifi-
cantly improve health outcomes if adopted as a dietary regimen’. Tufts also noted 
that ‘the research itself was found not to have been conducted in full compliance 
with IRB policy or federal regulations’ [43].
Eventually following this Greenpeace Press release, Tang et al. (2012) was 
retracted by the American Society of Clinical Nutrition in 2015 for procedural rea-
sons. The full details of this and other impediments to Golden Rice’s development 
are given elsewhere [6, 9, 10, 43].
Separately, the Chair of the Tufts IRB, a computer scientist, in complaint to the 
publisher of one critical review of the case [10], wrote: ‘There was no research ethics 
committee or IRB review and approval in effect for the study when it was conducted 
in 2008’. This gross error of fact, with reference to the NIH grant and related 
IRB authorisations quoted above, itself calls into question the professionalism or 
objectivity of the 2012 Tufts IRB review which led to the retraction. (The research 
sophistication and quality of the retracted paper can be reviewed online [44]).
Henry Miller, a physician, molecular biologist and the founding director of the 
US Food and Drug Administration (FDA), commented in 2015 on the retracted 
paper: ‘A 2012 article in the nutrition literature might have been the most momen-
tous contribution to public health worldwide since Dr. Jonas Salk’s announcement 
of the polio vaccine. The operative phrase is might have been, because intimidation, 
politics and the dishonest, anti-science efforts of NGOs to impugn the research have 
delayed the translation of its findings to life-saving interventions for millions of 
children. Why do anti-genetic engineering activists want to save the whales but let 
children go blind and die?’ [45].
The data generated by the above-mentioned research allow determination of the 
proportion of the estimated average requirement (EAR) the β-carotene content of 
Golden Rice can provide to children and adults (Table 2). If Golden Rice was the 
sole source of β-carotene in the diet, 50% of the EAR is sufficient to combat VAD 
[46]. Many nutritionists consider that supply of 30–40% of the EAR will be suf-
ficient to combat VAD because the biofortified staple crop is seldom the only source 
of β-carotene. (The recommended daily allowance—RDA—which implies mainte-
nance of 3-months liver stores of vitamin A, is not required to combat VAD.) The 
calculations (Table 2) use the β-carotene levels observed in different Golden Rice 
cultivars (e.g. RC82, BR29, IR36, IR64) of Golden Rice GR2E 2 months after har-
vest, when degradation has stabilised. A 6% loss of β-carotene in cooking Golden 
Rice, or 25% loss of β-carotene when a Golden Rice meal is parboiled first, and then 
reheated, has not been taken into account.
3 http://www.greenpeace.org/eastasia/news/blog/24-children-used-as-guinea-pigs-in-geneticall/
blog/41956/
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3.3 Is Golden Rice safe?
Golden Rice differs from white rice only in that it contains β-carotene, that is, 
provitamin A, which the human body converts to vitamin A. Golden Rice contains 
no vitamin A itself. So the question about safety relates principally to β-carotene, 
which is anyway ubiquitous in a balanced human diet and the environment.
At the levels found in food, β-carotene is a safe source of vitamin A, and classed 
as ‘generally recognised as safe’ (GRAS), by the United States Food and Drug 
Administration (US FDA) [47, 48]. At these physiological doses, consumption of 
β-carotene over several years has no adverse health effects [49–52]. The human 
body only converts to vitamin A, in the form of circulating retinol, the amount of 
β-carotene necessary, with the rest being excreted or stored unchanged in body tis-
sues (e.g. fat, liver, etc.). It is impossible to induce vitamin A toxicity by consuming 
β-carotene (pers. comm. Dr. R Russell).
In all β-carotene-containing crops, immediately after harvest the level of 
β-carotene reduces. For Golden Rice carotenoid degradation mechanisms have been 
thoroughly investigated4 and the products of degradation quantitated. Additionally, 
102 plant food items from Philippine markets, together with orange- or yellow-
coloured soft drinks, as well as non-gmo field grown, in all cases, orange maize cobs 
and yellow cassava storage roots from Zambia, and orange-fleshed sweet potato 
tubers from Uganda, were analysed for the cleavage products of β-carotene, apoca-
rotenoids [53]. The potential risks arising from ‘aberrant plant carotenoid synthesis’ 
[54] in genetically modified plants, including Golden Rice, or from non-gmo crops 
biofortified with pro-vitamin A, have been thoroughly investigated, the authors 
4 Golden Rice cv. Kaybonnet was investigated because it was available [5] and has high degradation poten-
tial. Kaybonnet is not a cultivar that will be used anywhere.
Amount of β-carotene in Golden Rice 
μg/g
Rice consumption per day (g of 
dry rice before cooking)
Percentage of EAR 
provided
β-carotene to circulating retinol bioconversion rate: 2.1:1 (e.g. children) To a childa
4.0 40 36%
4.0 100 91%
6.0 40 54%
6.0 100 136%
11.2 40 102%
11.2 100 254%
β-carotene to circulating retinol bioconversion rate: 3.8:1 (e.g. adults) To an adult
4.0 40 20%
4.0 100 50%
6.0 40 30%
6.0 100 75%
11.2 40 56%
11.2 100 140%
aFor 1- to 3-year-old child, 100% of EAR is 210 μg RAE/day. An EAR that does not ensure adequate stores but is 
enough for normal dark adaptation is set at 112 μg ~50% EAR [46]
Table 2. 
The potential for Golden Rice to deliver the estimate average requirement of β-carotene, as a source of vitamin A, 
to 1–3-year-old children and adults.
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reporting that ‘Our analysis and quantification of β-carotene derived cleavage 
products across biofortified and non-biofortified crop plant tissues combined with 
the calculation of potential exposure document no reason for concern’ [53].
For the formal regulatory approvals for the use of a gmo crop in food, as animal 
feed or in food or feed processing, on a country by country basis, detailed data sets 
have to be submitted. For permission to grow a gmo crop in a country, additional 
data have to be generated5 and submitted showing environmental safety.6 The ‘food, 
feed and processing’ data package developed for Golden Rice GR2E is extensive (42 
megabytes of data). It is available without cost to all Golden Rice licensee countries 
consistent with long-standing Golden Rice Humanitarian Board policy. Here are the 
key summaries of the regulatory data submission made in the Philippines:
“PROPOSAL FOR DIRECT USE AS FOOD AND FEED, OR FOR PROCESSING
Provitamin A Biofortified GR2E Rice
Description of the Regulated Article for Direct Use
Rice event GR2E (IR-ØØGR2E-5) was developed using recombinant-DNA techniques 
to express elevated levels of provitamin A (mainly β-carotene) in the rice endosperm, 
which is converted in the body to vitamin A. GR2E rice was produced by Agrobacterium 
tumefaciens-mediated transformation of embryogenic rice calli with plasmid pSYN12424 
resulting in the introduction of the phytoene synthase (psy1) gene from Zea mays 
(Zmpsy1), the carotene desaturase I (crtI) gene from Pantoea ananatis,7 and the phospho-
mannose isomerase (pmi) gene from Escherichia coli as a selectable marker.
GR2E rice is intended to complement existing efforts to mitigate vitamin A deficiency 
by supplying consumers in societies whose diet is primarily rice-based with a portion of 
the estimated average requirement for vitamin A.
Summary of Potential Effects on Human and Animal Health
The safety assessment of GR2E rice evaluated information on the history of safe use 
of rice as a crop, the source of donor genes introduced into GR2E rice, the molecular 
characterisation of the modified plant, the stability of the inserted genetic elements, 
characterisation of new proteins produced in the modified plant and their expression 
levels, the potential allergenicity and potential toxicity of the newly expressed proteins, 
and the nutrient composition of GR2E rice compared to conventional rice.
Molecular characterisation of the introduced DNA within event GR2E confirmed 
the presence at a single insertion site of one copy of the inserted DNA that was stably 
inherited over multiple generations as a single genetic locus per Mendelian rules of 
inheritance. Expression of the ZmPSY1 and CRTI proteins was limited to the rice 
endosperm with maximum concentrations in mature grain of approximately 0.245 and 
0.03 ppm, respectively. The PMI protein was expressed in all rice tissues measured  
and accumulated to maximum concentrations of 1.89 and 0.796 ppm in mature  
grain and straw, respectively.
A tiered “weight-of-evidence” approach was followed in assessing the safety of the 
ZmPSY1, CRTI, and PMI proteins expressed in GR2E rice. The ZmPSY1 and CRTI 
proteins did not display significant amino acid sequence similarity with known aller-
gens nor were there any primary sequence structural alerts for potential toxicity based 
on similarity searches against a database of known and putative protein toxins. Both 
ZmPSY1 and CRTI were rapidly and completely digested in the presence of simulated 
gastric fluid containing pepsin, and the enzymatic activity of both proteins was destroyed 
following treatment at temperatures well below those used during cooking.
5 Agronomic/phenotypic data and related studies for GR2E Golden Rice can be found at: http://www.
agbios.org/?page_id=767
6 The regulations exist and have to be complied with. Nevertheless, many disagree that they are justified 
[6, 10, 59, 73–76].
7 This is the same organism as Erwinia uredovora [2, 5]. The name was changed.
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Due to the non-food source of the crtI gene, acute oral toxicity testing of CRTI protein 
in mice was conducted as a further assurance of safety and demonstrated a lack of any 
observable adverse effects at a dose of 100 mg/kg body weight, which represents at least a 
115,000-fold margin of exposure relative to any realistically conceivable human dietary 
intake from GR2E rice.
Based on its presence in a wide range of food and feedstuffs derived from genetically 
engineered maize lines, and on the extensive history of prior regulatory reviews in the 
Philippines, additional characterisation of the PMI protein was unnecessary. Previously 
submitted safety studies reviewed in the context of other genetically engineered plant events 
are directly applicable to the safety assessment of PMI protein expressed in GR2E rice.
The genetic modification resulting in GR2E rice was only intended to increase levels 
of provitamin A (primarily β-carotene) in the rice endosperm. To confirm the intended 
effect and the lack of any meaningful unintended consequences of the genetic modification, 
compositional parameters were compared between GR2E rice and control, unmodified, 
rice. Compositional analyses were performed on samples of rice grain and straw obtained 
from PSB Rc82 rice containing event GR2E and near-isogenic control PSB Rc82 rice that 
was grown at four separate sites in the Philippines during 2015 and again in 2016. The 
compositional assessment included analyses for proximates, fibre, and minerals in samples 
of straw, and analyses for proximates, minerals, vitamins, amino acids, fatty acids, 
vitamins, and key anti-nutrients in grain samples. Samples of processed bran derived from 
GR2E and control rice were also analysed for proximates, fibre, and minerals.
Among the 69 compositional components that were tested for in samples of GR2E 
and control PSB Rc82 rice grain, and 10 components that were assessed in derived 
bran and straw samples, the only statistically significant difference observed from 
the multi-year combined-site analysis was for stearic (C18:0) acid, a minor fatty 
acid component, measured in grain samples (not including the intended difference in 
provitamin A levels). Except for β-carotene and related carotenoids, the compositional 
parameters measured in samples of GR2E rice, including stearic acid, were within or 
similar to the range of natural variability of those components in conventional rice 
varieties with a history of safe consumption. Overall, no consistent patterns emerged 
to suggest that biologically meaningful changes in composition or nutritive value of the 
grain or straw had occurred as an unexpected, unintended consequence of the genetic 
modification.
Collectively, the studies performed for GR2E rice have not identified potential health 
and safety concerns, and support the conclusion that food and/or livestock animal feed 
derived from provitamin A biofortified GR2E rice is as safe and nutritious as food or feed 
derived from conventional rice varieties.”
Although it is hard to imagine that such golden grains of polished Golden Rice 
could be included in commercial shipments of white rice by accident, in the modern 
world, any such inclusion could be damaging to international trade. To prevent even 
such an unlikely situation, the Golden Rice regulatory data have been submitted 
to regulatory authorities in countries which import rice, where VAD is not a public 
health issue. As a result of these data submissions, Golden Rice GR2E has been 
confirmed as safe for use as food, in feed, and for processing by the government’s 
regulatory authorities in Australia, Canada, New Zealand and USA. The regulatory 
deliberations and decisions are publicly available: Australia and New Zealand,8 
Canada9 and the USA.10
8 http://www.foodstandards.gov.au/code/applications/Pages/A1138GMriceGR2E.aspx
9 https://www.canada.ca/en/health-canada/services/food-nutrition/genetically-modified-foods-other-
novel-foods/approved-products/golden-rice-gr2e.html
10 https://www.accessdata.fda.gov/scripts/fdcc/?set=Biocon&id=IR-00GR2E-5
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Because in these industrialised countries rice forms only a tiny proportion of 
standard diets which already contain ample sources of vitamin A, the amounts of 
β-carotene in Golden Rice would have no significant additional nutritional benefit 
there. Comments to this effect by the US regulatory authorities were implied by 
anti-gmo crop opponents to be applicable also in developing countries where the 
dietary situation is completely different. Such implication has been rebutted by 
the US FDA [55]. The regulators in these industrialised countries concurred with 
Tufts University’s statement issued after their investigation of the ‘Chinese children’ 
research: ‘… Golden Rice, …could significantly improve health outcomes if adopted 
as a dietary regimen’ [43].
Further regulatory submissions have been made, and registrations are expected, 
in countries where VAD is a public health problem [56]. In the Philippines the pro-
cess is not yet complete; nevertheless various government departments have already 
expressed their support.11
Gmo crops have been vilified by activist groups since the 1990s. ‘Frankenstein 
foods’ were used in a letter in the New York Times on June 16, 1992. The Daily Mail, a 
UK newspaper, headlined the same phrase in February 1998 and subsequently and 
extensively used ‘Frankenfoods’ [57]. The ‘anti-gmo groups’, in various guises, have 
been critical of Golden Rice, a gmo crop, since 2001 [6, 10, 40].
Notwithstanding this opposition, all independent scientific institutions globally 
have determined, for many years, that there is no inherent danger to crop plants, or 
the human use of crops plants, or the environment from transferring genes from 
one organism to another, to create gmo crops, also known as genetically engineered 
(GE) crops, including transfer of genes between species which cannot sexually 
reproduce to transfer the genes ‘naturally’ [6, 58, 59].
Norero [60] provides a list of more than 240 independent science institutions 
from all over the globe which have commented on the safety of the techniques of 
genetic modification. A particularly clear reference comes from the heart of the 
geography politically most opposed to gmo technology, the European Commission 
of the European Union:
‘The main conclusion to be drawn from the efforts of more than 130 research 
projects, covering a period of more than 25 years of research and involving more 
than 500 independent research groups, is that biotechnology, and in particular 
GMOs, are not per se more risky than, for example, conventional plant breeding 
technologies’ [61].
At the time of writing, 141 Nobel Laureates, of about 290 living, have signed an 
open letter dated June 29, 2016, addressed to the leaders of Greenpeace, the United 
Nations and governments around the world calling for the campaign against Golden 
Rice specifically, and crops and foods improved through biotechnology in general, 
to cease ‘Opposition based on emotion and dogma contradicted by data must be 
stopped’ [8]. The letter also has the support of more than 13,000 other scientists 
and citizens.
3.4 Is Golden Rice economic?
Golden Rice seed and regulatory data packages are available—without cost—to 
public-sector rice-breeding institutions in less developed countries where rice is 
the staple and vitamin A deficiency endemic. Supply is subject only to national 
and international regulations and simple and free agreements [4]. The licences 
11 http://www.agbios.org:8085/wp-content/uploads/2018/07/Consolidated-Report-gr2e-rice_revised-1.
pdf
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ensure that the inventor’s, Professors Potrykus and Beyer, objectives for their 
donated technology cannot be frustrated: only publicly owned rice varieties can 
be used, and the nutritional trait cannot be ‘stacked’ with any other gmo trait, 
unless the latter is also under the control of the public sector. There will be no 
charge to growers or consumers for the nutritional trait: Golden Rice will cost the 
same as white rice. Golden Rice homozygous seed, which breeds true generation 
to generation, will be provided by public-sector rice breeders. All small-holder 
family farmers—responsible for 80% of global rice production [38]—will eventu-
ally have access to it, with (except for commercial export—not a resource-poor 
farmer activity) no limitations on planting or replanting, harvest or sale of seed 
or grain.
Addressing micronutrient malnutrition, including VAD, is consistently ranked 
by the Copenhagen Consensus process, as the first, or at least within the top 5, 
most cost-effective investments with the potential to address the world’s 30 most 
intractable problems [62–64]. Investing in alleviating malnutrition would repay 
$45 for each dollar invested compared with $36 from fighting malaria and $10 from 
combatting HIV [65].
Compared with the World Bank standard, or the full cost of provision of vitamin 
A capsules, a common dietary supplement intervention for VAD since the early 
1990s [15, 22], the cost of Golden Rice to save each disability-adjusted life year 
(DALY) is expected to be very low, perhaps US$0.5 [9, 66, 67].
Economists have calculated that conservative adoption of Golden Rice would 
benefit the gross domestic product (GDP) of Asian countries by US$6.4 bil-
lion (value in US$ of 2005) annually through increased productivity enabled 
by reduced vitamin A deficiency-induced sickness, and improved eyesight, and 
~US$17.4 billion (value in US$ of 2005) if Golden Rice adoption encouraged 
adoption of other nutritional traits in rice [68]. Recently, HarvestPlus has exceeded 
target levels of iron and zinc in rice, which they were unable to achieve by conven-
tional breeding, using gmo techniques [16]. Genetic modification has also been 
used to introduce folate into rice endosperm [27, 69]. The delay to the introduc-
tion of Golden Rice in India has been calculated to have cost Indian GDP US$199 
million per annum for the decade from 2002 [70, 71], in total about US$1.7 billion 
(value in US$ of 2014).
Costs (US$ of 2006) Highest efficiency Lowest efficiency
World Bank cost-effective standarda $200 $200
Providing vitamin A capsulesa $134 $599
Vitamin A fortification of fooda $84 $98
Golden Rice, India @ 12:1a $3.10 $19.4
Golden Rice, Bangladesh 6:1b & 12:1c $4.0b $54.0c
Golden Rice, abovea,b,c adjusted 2.1:1d $0.5 $1.4 $3.4 $9.5
The earlier studies occurred before these bioconversion ratios had been elucidated
aSource: [66]
bSource: [67]
cSource: [67]
dSource: From the bioconversion efficiency 2.1:1 Table 2
Table 3. 
Relative costs of saving one disability-adjusted life year using different sources of vitamin A and, for Golden 
Rice, different bioconversion ratios of β-carotene to circulating vitamin A.
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Adoption of biofortified crops, including Golden Rice, will facilitate attainment of 
six of the most important Sustainable Development Goals 2015–2030 (Table 4). The 
standard costs used by the economists referenced in Tables 3 and 4 [62–64, 66, 67] 
refer to the costs of supplementation with vitamin A capsules. As when using Golden 
Rice, the vitamin A source has zero cost to the grower or consumer; the cost benefit of 
Golden Rice will be very significantly better than using vitamin A capsules.
4. Conclusions
Vitamin A deficiency remains a huge public health problem despite existing 
interventions. Biofortification of staple foods is a new policy priority internation-
ally. Golden Rice is safe. There is excellent human evidence that it will work. It is 
expected to be extremely cost-effective.
For successful adoption of Golden Rice as an additional intervention for vitamin 
A deficiency, the support of public health professionals is critical.
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Goal # Goal Potential impact of biofortification
1 No poverty Micronutrients in staple crops reduce effects
2 Zero hunger Whole populations will be micronutrient sufficient
3 Good health Provitamin A, Fe, Zn, Folate: less morbidity and mortality
4 Quality education Pupils learn when adequately fed: Fe important
5 Gender equality Biofortified staples available to whole population
7 Decent work and 
economic growth
Increased productivity from biofortified rice alone will add 
US$17.4 (in US$ of 2005) to Asian GDP
Table 4. 
Biofortification and some Sustainable Development Goals 2015–2030.
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